These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7184421)

  • 41. [A case of recurrence after resection of stage IV advanced bile duct cancer responding well to S-1/cisplatin combination chemotherapy].
    Mori Y; Katsumata K; Tokita H; Kato F; Yamamoto J; Tsuchida A; Aoki T
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1485-7. PubMed ID: 17876152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice.
    Türkçapar N; Bayar S; Koyuncu A; Ceyhan K
    Hepatogastroenterology; 2003; 50(51):680-3. PubMed ID: 12828059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Trial of home anti-cancer chemotherapy with infusion of 5-FU and low-dose cisplatin].
    Muto A; Ashino Y; Ito H; Kanno A; Moriyama A; Hiraga M
    Gan To Kagaku Ryoho; 1996 Dec; 23 Suppl 3():245-50. PubMed ID: 8982309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advanced bile duct carcinoma in a 15-year-old patient with pancreaticobiliary maljunction and congenital biliary cystic disease.
    Nakamura H; Katayose Y; Rikiyama T; Onogawa T; Yamamoto K; Yoshida H; Hayashi H; Ohtsuka H; Hayashi Y; Egawa S; Unno M
    J Hepatobiliary Pancreat Surg; 2008; 15(5):554-9. PubMed ID: 18836813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extended extrahepatic bile duct resection to avoid performing pancreatoduodenectomy in patients with mid bile duct cancer.
    Hwang S; Lee SG; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH
    Dig Surg; 2008; 25(1):74-9. PubMed ID: 18292664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of curatively resected biliary tract cancer with peritoneal dissemination through effective response to chemotherapy of S-1].
    Kanaji S; Kobayashi I; Fujita T; Ueno K; Tsuchida S; Kawasaki K; Ohno M; Osawa M; Fujino Y; Tominaga M; Nakamura T
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1337-9. PubMed ID: 19692774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cure of advanced cancer by diet therapy: a summary of 30 years of clinical experimentation.
    Gerson M
    Physiol Chem Phys; 1978; 10(5):449-64. PubMed ID: 751079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pathologic conference no. 495. Obstructive jaundice in a child.
    J Iowa Med Soc; 1968 May; 58(5):490-501. PubMed ID: 5647670
    [No Abstract]   [Full Text] [Related]  

  • 49. Response to doxorubicin and mitomycin in cholangiocarcinoma: a case report.
    Adolphson CC; Carpenter JT
    Cancer Treat Rep; 1982 Jan; 66(1):209-10. PubMed ID: 6272991
    [No Abstract]   [Full Text] [Related]  

  • 50. Carcinogenesis in the biliary tract; the apparent induction of intestinal and liver cancers by subcutaneously injected bile.
    FORTNER JG
    Cancer; 1956; 9(6):1163-6. PubMed ID: 13383447
    [No Abstract]   [Full Text] [Related]  

  • 51. Emerging drugs for biliary cancer.
    Okusaka T; Ojima H; Morizane C; Ikeda M; Shibata T
    Expert Opin Emerg Drugs; 2014 Mar; 19(1):11-24. PubMed ID: 24354562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Primary neoplasms of the biliary tract].
    De la Torre Carrasco F; Naranjo Gómez A; Cuadrado Mangas C
    Rev Clin Esp; 1974 Mar; 132(6):523-32. PubMed ID: 4840222
    [No Abstract]   [Full Text] [Related]  

  • 53. [Our cases of primary cancer of the choledochus].
    Ján H; Asztalos B; Simó G; Bujalka R
    Orv Hetil; 1970 Aug; 111(32):1885-7. PubMed ID: 5470593
    [No Abstract]   [Full Text] [Related]  

  • 54. [Ampicillin and the biliary tract (experimental research)].
    Giordanengo G; Vasario V; Riccardino N; Perinetti G
    Minerva Med; 1965 Sep; 56(73 Suppl):3090-4. PubMed ID: 5838810
    [No Abstract]   [Full Text] [Related]  

  • 55. Bile duct cancer is not hopeless.
    Vennes JA
    Gastrointest Endosc; 1989; 35(3):267-8. PubMed ID: 2759404
    [No Abstract]   [Full Text] [Related]  

  • 56. [Intraductal chemotherapy of bile duct cancer with 5-fluorouracil].
    Schmeck HJ; Bartels E; Viets CH; Arnold W
    Klin Wochenschr; 1986 Aug; 64(15):713-6. PubMed ID: 2429017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intrabiliary tract administration of adriamycin in bile duct cancer].
    Mizuno I; Tanada F; Iwai A; Kato F; Yura J
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):681-7. PubMed ID: 7184421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Intrabiliary administration of doxorubicin for pancreaticobiliary cancer].
    Nagahama T; Maruyama M; Nakamura N; Irie T; Yoshida T; Kure N; Ebuchi M
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1849-52. PubMed ID: 10560410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Two cases of advanced extrahepatic bile duct cancer successfully treated by S-1 monotherapy].
    Ueno H; Ikeda M
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1311-4. PubMed ID: 17687221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.